Sen. Patrick J. Toomey sold Revelation Biosciences (REVB)
Sen. Patrick J. Toomey (R-PA) · $1K–$15K · traded Apr 30, 2018
- Transaction
- Sold (partial)
- Amount
- $1K–$15K
- Owner
- The member
- Traded
- Apr 30, 2018
- Disclosed
- May 15, 2018
- Days to disclose
- 15
- Asset type
- Stock
- As filed
- Revere Bank
- Industry
- Biotechnology · Healthcare
Other trades in this filing
- May 15, 2018$1K–$15K
$1K–$15K · Traded Apr 23, 2018 · disclosed May 15, 2018
Recent Congress trades in REVB
- Aug 12, 2019$15K–$50K
Sen. Patrick J. Toomey (R-PA)
Sold (partial) Revelation Biosciences REVB
$15K–$50K · Traded Jul 27, 2018 · disclosed Aug 12, 2019 · Joint · filed 381 days later
- Aug 12, 2019$15K–$50K
Sen. Patrick J. Toomey (R-PA)
Sold (partial) Revelation Biosciences REVB
$15K–$50K · Traded Jul 27, 2018 · disclosed Aug 12, 2019 · filed 381 days later
- Aug 12, 2019$1K–$15K
Sen. Patrick J. Toomey (R-PA)
Sold (partial) Revelation Biosciences REVB
$1K–$15K · Traded Jun 25, 2018 · disclosed Aug 12, 2019 · Joint · filed 413 days later
- Aug 12, 2019$15K–$50K
Sen. Patrick J. Toomey (R-PA)
Sold (partial) Revelation Biosciences REVB
$15K–$50K · Traded Jun 6, 2018 · disclosed Aug 12, 2019 · Joint · filed 432 days later
- Aug 12, 2019$1K–$15K
Sen. Patrick J. Toomey (R-PA)
Sold (partial) Revelation Biosciences REVB
$1K–$15K · Traded May 16, 2018 · disclosed Aug 12, 2019 · Joint · filed 453 days later
- Aug 12, 2019$1K–$15K
Sen. Patrick J. Toomey (R-PA)
Sold (partial) Revelation Biosciences REVB
$1K–$15K · Traded Apr 30, 2018 · disclosed Aug 12, 2019 · Joint · filed 469 days later
- Aug 12, 2019$1K–$15K
Sen. Patrick J. Toomey (R-PA)
Sold (partial) Revelation Biosciences REVB
$1K–$15K · Traded Mar 22, 2018 · disclosed Aug 12, 2019 · Joint · filed 508 days later
- Aug 12, 2019$1K–$15K
Sen. Patrick J. Toomey (R-PA)
Sold (partial) Revelation Biosciences REVB
$1K–$15K · Traded Feb 8, 2018 · disclosed Aug 12, 2019 · Joint · filed 550 days later
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.